Mapping how B cells protect against alphavirus infections
Building an atlas of B cell mediated protective immunity to alphaviruses
['FUNDING_CAREER'] · WASHINGTON UNIVERSITY · NIH-11033426
This study is looking at how certain immune cells called B cells help protect us from alphaviruses, which can cause serious illnesses, and it aims to find ways to boost our immune responses or create better vaccines to fight these viruses.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-11033426 on ClinicalTrials.gov |
What this research studies
This research aims to create a detailed atlas of how B cells contribute to protective immunity against alphaviruses, which are a group of viruses that can cause serious diseases. By analyzing the immune responses generated by B cells, the research will explore the mechanisms of antibody production and how these antibodies can effectively neutralize the viruses. Patients may benefit from insights gained into how to enhance immune responses or develop vaccines targeting these infections. The research will involve advanced techniques in immunology and collaboration with experienced mentors in the field.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with a history of alphavirus infections or those at risk of exposure.
Not a fit: Patients who do not have a history of alphavirus infections or are not at risk may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for alphavirus infections, enhancing patient immunity.
How similar studies have performed: Previous research has shown success in mapping immune responses to other viral infections, suggesting potential for similar breakthroughs in this area.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RAJU, SARAVANAN — WASHINGTON UNIVERSITY
- Study coordinator: RAJU, SARAVANAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alphavirus Infections